Early asymptomatic nasopharyngeal carcinoma (NPC) will possibly be detectable by plasma Epstein-Barr virus (EBV) DNA analysis, according to a new study carried out by the Chinese University of Hong Kong (CUHK).
It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use.
What’s the import and export situation of medical dressing in China? And what are the prospects of this industry? Today, pharmaceutical and medical devices online platform, Ddu, brings you the breakdown with our Medical Dressing Market Analysis Report.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.